Construction of a new patient-derived xenograft model of human liver cancer in mice with normal immunity
ObjectiveTo establish a new patient-derived xenograft (PDX) model of human liver cancer by inoculating the complex of human primary liver cancer cells and a novel microcarrier (microcarrier 6) into mice with normal immune function. MethodsPrimary liver cancer cells were isolated and extracted from t...
Guardado en:
Autor principal: | TANG Huixin |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Department of Journal of Clinical Hepatology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/309ed71879e7419ba0f168fd34394941 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease
por: ZHANG Jie
Publicado: (2021) -
Leukocyte‐Derived High‐Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes
por: Annika Volmari, et al.
Publicado: (2021) -
Epidemiology of drug-induced liver injury
por: LI Xiaoyun
Publicado: (2021) -
Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
por: LI Pinhua
Publicado: (2021) -
Clinical manifestations and typing of drug-induced liver injury
por: YANG Wanna
Publicado: (2021)